The Future of
Musculoskeletal Research
At MSK Doctors Research, we bridge the gap between academic innovation and real-world clinical care. From AI-powered motion analysis to 10-year implant durability studies, our work defines the standards of joint preservation and functional longevity.
A Network of Excellence in
Clinical Innovation
Clinical Research Programmes
Current Studies &
Active Clinical Trials
Our ongoing research initiatives focus on long-term patient outcomes, innovative implant technologies, and the validation of digital health tools within UK orthopaedic care.
A prospective non-interventional programme tracking real-world function, implant integrity, and patient-reported outcomes over 10 years after U2 MB™ knee replacement.
Follow-up
10 Years
Design
Non-Interventional
Population
UK Focus
A structured 24-week pathway evaluating non-compressive, drug-free therapy for Achilles tendinopathy, including serial imaging and functional monitoring.
Protocol
24 Weeks
Imaging
2 Open MRI Scans
Therapy
100% Drug-Free
Emerging Clinical Initiatives
Upcoming Research
Programmes currently being structured for clinical launch, with study design, functional recovery targets, and partner delivery pathways already taking shape.
Upcoming Programme
Regen EMS™
Quadriceps Recovery After Knee Surgery
MSK Doctors is preparing to launch a prospective controlled clinical study exploring whether targeted, non-invasive EMS can reduce early quadriceps wasting and support functional recovery after knee surgery.
Methodology
Non-Invasive EMS
Focus Area
Muscular Atrophy
Lead Partner
MSK Research Lab
Upcoming Programme
SENSUIT™
Space-Health Innovation for Musculoskeletal Monitoring
MSK Doctors is advancing SENSUIT™ as a translational innovation programme combining AI, smart textiles, and the MAI Motion Platform to deliver continuous musculoskeletal insight from extreme environments to preventative healthcare on Earth.
Capability
AI Driven
Interface
Smart Textiles
Platform
MAI Motion
Completed Studies & Programmes
Evidence That
Compounds Over Time.
A published foundation spanning long-term arthroplasty follow-up, Innovate UK-funded digital health programmes, wearable innovation, and internationally-recognised AI motion analysis.
10-Year Outcomes
EVOLUTION® NitrX™
10-Year Multicentre Clinical Follow-Up
24-Month Programme
MSK Digital Platform
Innovate UK Knowledge Transfer Partnership
18-Month Programme
Smart-MOTION®
Innovate UK Biomedical Catalyst — £480,000
Santander X 2025
MAI Motion
Santander X Global Challenge — Top 10 Finalist
Published Study
Sit-to-Stand Validation
Empirical Validation Using MAI Motion
The Innovation Pipeline
Programmes developed for competitive funding routes and continuing to evolve within our active innovation pipeline. These initiatives represent our commitment to pushing the boundaries of musculoskeletal science.
Next-Generation
Biologic Scaffolds
Investigating bio-integrative materials for early-stage cartilage repair. This programme continues to undergo refinement for UKRI-specific competitive funding cycles.
Computer Vision in
Post-Surgical Tracking
A high-frequency motion capture framework designed for remote patient monitoring. Currently evolving to meet NIHR digitisation standards.
Value-Based Healthcare
Outcome Modelling
Developing a robust methodology for measuring long-term economic impact of joint preservation over replacement.
Academic & Clinical Collaboration
We are actively seeking strategic partners and academic consortiums to accelerate these programmes towards clinical reality.
For Our Patients
Advancing Medicine.
Empowering Recovery.
At MSK Doctors Research, we believe that private healthcare should be more than just service—it should be the engine of medical progress. We bridge the gap between laboratory innovation and clinical excellence, ensuring our patients are the first to benefit from evidence-led, future-proof orthopaedic care.
Evidence-Led Decisions
We move beyond "opinion-based" medicine. Every surgical technique and implant we offer is backed by rigorous data and peer-reviewed research.
Safety & Governance
Patient safety is our absolute priority. Our research adheres to the highest UK ethical standards, ensuring innovation never compromises care.
Global Impact
By choosing us, you are part of a global movement. Your journey contributes to the data that will define orthopaedic standards for the next generation.
Next-Gen Technology
We invest in non-invasive tracking and biological solutions, aiming to restore your lifestyle with less effort and more insight into your recovery.
100%
Evidence Driven
UK-Based
Clinical Research
"Our mission is to ensure that every patient benefits from the most advanced, safe, and effective musculoskeletal treatments available globally."